STML - Stemline Therapeutics Inc. (STML) CEO Ivan Bergstein on Q2 2019 Results - Earnings Call Transcript
Stemline Therapeutics, Inc. (STML)
Q2 2019 Earnings Conference Call
August 02, 2019, 08:00 ET
Company Participants
Kenneth Hoberman - COO & Corporate Secretary
Ivan Bergstein - Founder, President, CEO & Chairman
Robert Francomano - SVP & Global Head, Commercial
David Gionco - VP, Finance & CAO
Conference Call Participants
Jessica Fye - JPMorgan Chase & Co.
Matthew Kaplan - Ladenburg Thalmann & Co.
Joseph Catanzaro - Piper Jaffray Companies
Raghuram Selvaraju - H.C. Wainwright & Co.
Boris Peaker - Cowen and Company
Presentation
Operator
Good day, and welcome to the Stemline second quarter earnings call.